Picture of Nanoform Finland Oyj logo

NANOFH Nanoform Finland Oyj Share Price

0.000.00%
fi flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m-20.16%
3m+41.77%
6m+12.16%
1yr+24.44%
Volume Change (%)
10d/3m-41.42%
Price vs... (%)
52w High-30%
50d MA-9.08%
200d MA+21.56%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-31.15%
Return on Equity-26.93%
Operating Margin-875.73%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Nanoform Finland Oyj EPS forecast chart

Profile Summary

Nanoform Finland Oyj is a Finland-based company that operates in the global pharmaceutical industry. The Company is an early-stage growth Company that develops various nanoforming technologies for application in the field of nanomedicine. Nanoform Finland Oyj’s business is to offer expert services in nanotechnology as well as drug particle engineering for global pharma and biotech industry. Nanoform Finland Oyj is the Parent Company of the Nanoform Group, and it has one subsidiary - Nanoform USA Inc. The Group production, research and development functions operate in Finland. The Group’s strategy is to sell nanotechnological services widely to minimize the dependence from single customers or projects.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    December 29th, 2015
    Public Since
    June 4th, 2020
    No. of Employees
    165
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    fi flag iconOMX Nordic Exchange - Helsinki
    Shares in Issue
    78,433,964

    NANOFH Share Price Performance

    Upcoming Events for NANOFH

    Nanoform Finland Oyj Annual Shareholders Meeting

    Nanoform Finland Oyj Annual Shareholders Meeting

    Q1 2024 Nanoform Finland Oyj Earnings Release

    Q2 2024 Nanoform Finland Oyj Earnings Release

    Similar to NANOFH

    Picture of Herantis Pharma Oyj logo

    Herantis Pharma Oyj

    fi flag iconOMX Nordic Exchange - Helsinki

    FAQ